Pages that link to "Q42929717"

The following pages link to Inhibition of cellular alpha DNA polymerase and herpes simplex virus-induced DNA polymerases by the triphosphate of BW759U (Q42929717):

Displaying 41 items.

• Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (Q24646311) (← links)
• Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses (Q28360393) (← links)
• Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir (Q28360471) (← links)
• Effects of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new antiherpesvirus compound, on synthesis of macromolecules in herpes simplex virus-infected cells (Q28365697) (← links)
• Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes (Q29547355) (← links)
• Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition (Q33646854) (← links)
• Targeting of an inducible toxic phenotype in animal cells (Q33654882) (← links)
• Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir (Q33739521) (← links)
• Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine (Q33743500) (← links)
• Metabolic activation of 9([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human lymphoblastoid cell lines infected with Epstein-Barr virus (Q33928152) (← links)
• Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infection (Q33980098) (← links)
• The enzymological basis for resistance of herpesvirus DNA polymerase mutants to acyclovir: relationship to the structure of alpha-like DNA polymerases (Q34812506) (← links)
• TAOK3 phosphorylates the methylenecyclopropane nucleoside MBX 2168 to its monophosphate. (Q35638861) (← links)
• Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on the acute local phase of herpes simplex virus-induced skin infections in mice and the establishment of latency (Q35644370) (← links)
• Comparison of the modes of antiviral action of 2'-nor-deoxyguanosine and its cyclic phosphate, 2'-nor-cyclic GMP. (Q35650395) (← links)
• The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy (Q36440044) (← links)
• A mouse model for X-linked adrenoleukodystrophy (Q36566796) (← links)
• Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene (Q36883978) (← links)
• Functional expression of a cloned herpes simplex virus type 1 DNA polymerase gene (Q36888196) (← links)
• Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus (Q36897832) (← links)
• Use of microorganisms for the study of drug metabolism: an update (Q37477727) (← links)
• Sequence and mapping analyses of the herpes simplex virus DNA polymerase gene predict a C-terminal substrate binding domain. (Q37538128) (← links)
• Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus (Q37684876) (← links)
• Reduced in vivo mutagenesis by mutant herpes simplex DNA polymerase involves improved nucleotide selection (Q37690766) (← links)
• Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition (Q37692343) (← links)
• Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections (Q37880547) (← links)
• In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir) (Q38529394) (← links)
• Gene Targeting in Neuroendocrinology (Q38596690) (← links)
• Significance of resistance of herpes simplex virus to acyclovir. (Q39174061) (← links)
• Chemotherapy of herpesvirus infections (Q39724203) (← links)
• Effect of duration and intensity of ganciclovir exposure on lymphoblastoid cell toxicity (Q39819129) (← links)
• Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems (Q40129395) (← links)
• Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information (Q40283743) (← links)
• Impaired mismatch extension by a herpes simplex DNA polymerase mutant with an editing nuclease defect (Q41011009) (← links)
• Cryptogenic colitis due to occult cytomegalovirus infection (Q41060045) (← links)
• 2'-nor-cGMP, a new cyclic derivative of 2'NDG, inhibits HSV-1 replication in vitro and in the mouse keratitis model (Q42206437) (← links)
• Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase (Q44365876) (← links)
• Efficacy of BW759 (9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine) against herpes simplex virus type 1 keratitis in rabbits (Q44525325) (← links)
• Synergistic effects on ganglionic herpes simplex virus infections by mutations or drugs that inhibit the viral polymerase and thymidine kinase (Q45784444) (← links)
• Antiviral agents (Q67514516) (← links)
• Antiviral Drug Resistance (Q67685039) (← links)